REG. NO. 40203507493 · Sabiedrība ar ierobežotu atbildību · REGISTERED 12/09/2023

SIA "RPH INVEST"

40203507493Active

Rīga, Grēdu iela 4A

SIA "RPH INVEST" is a Latvian limited liability company registered in 2023. Its primary line of business is activities of holding companies (NACE 64.21).

Overview Financials Ownership VID Data Documents Pledges Risk Network

REG. NO. 40203507493 · Sabiedrība ar ierobežotu atbildību · REGISTERED 12/09/2023

SIA "RPH INVEST"

40203507493Active

Rīga, Grēdu iela 4A

SIA "RPH INVEST" is a Latvian limited liability company registered in 2023. Its primary line of business is activities of holding companies (NACE 64.21).

Overview Financials Ownership VID Data Documents Pledges Risk Network

Key FactsEnterprise Register · 19/11/2025

Legal form: Sabiedrība ar ierobežotu atbildību
Registration date: 12/09/2023
SEPA code: LV94ZZZ40203507493
Address: Rīga, Grēdu iela 4A
Region: 0
Equity capital: €81,050,000
NACE code: 64.2164.21 Activities of holding companies
Industry sector: LL › 64 › 64.2 › 64.21
Historical names: —

StatusEnterprise Register · 19/11/2025

No issues detected

InsolvencyNone

LiquidationNone

VID suspensionsNone

SanctionsNone

Securing measuresNone

ReorganizationNone

Key Financials (2024)data for 2024

Revenue

€0

Net income

€1,746,068

Total assets

€83,027,798

Equity capital

€82,796,068

Employees

Profit margin

—

Current Ratio

277.44

ROA

2.1%

Financial History

Insufficient data

ShareholdersEnterprise Register · 19/11/2025

JUR.AS "RECIPE PLUS"

43.18%35,000,000

JUR.Sabiedrība ar ierobežotu atbildību "CENTRĀLĀ LABORATORIJA"

37.01%30,000,000

JUR.AS "RPH MARKETING LATVIA"

18.51%15,000,000

JUR.AS "NIPO"

1.23%1,000,000

JUR.AS "Repharm"

0.06%50,000

Beneficial Owners

Officials

Executive Board

Korņijenko Sergejs

Board Member

Tavjevs Roberts

Chair of Board

Power of AttorneyEnterprise Register · 19/11/2025

No prokūra data

Timeline

19/11/2025

UBO declared: Sergejs Korņijenko

Sergejs Korņijenko

19/11/2025

UBO declared: Andrejs Leibovičs

Andrejs Leibovičs

19/11/2025

UBO declared: Roberts Tavjevs

Roberts Tavjevs

21/11/2023

Capital: Apmaksātais pamatkapitāls 81050000 EUR

81050000 EUR

15/11/2023

SIA shareholder: AS "Repharm" (50000 shares)

AS "Repharm" (50000 shares)

15/11/2023

SIA shareholder: AS "RECIPE PLUS" (35000000 shares)

AS "RECIPE PLUS" (35000000 shares)

15/11/2023

SIA shareholder: Sabiedrība ar ierobežotu atbildību "CENTRĀLĀ LABORATORIJA" (30000000 shares)

Sabiedrība ar ierobežotu atbildību "CENTRĀLĀ LABORATORIJA" (30000000 shares)

15/11/2023

SIA shareholder: AS "RPH MARKETING LATVIA" (15000000 shares)

AS "RPH MARKETING LATVIA" (15000000 shares)

Key FactsEnterprise Register · 19/11/2025

Legal form: Sabiedrība ar ierobežotu atbildību
Registration date: 12/09/2023
SEPA code: LV94ZZZ40203507493
Address: Rīga, Grēdu iela 4A
Region: 0
Equity capital: €81,050,000
NACE code: 64.2164.21 Activities of holding companies
Industry sector: LL › 64 › 64.2 › 64.21
Historical names: —

StatusEnterprise Register · 19/11/2025

No issues detected

InsolvencyNone

LiquidationNone

VID suspensionsNone

SanctionsNone

Securing measuresNone

ReorganizationNone

Key Financials (2024)data for 2024

Revenue

€0

Net income

€1,746,068

Total assets

€83,027,798

Equity capital

€82,796,068

Employees

Profit margin

—

Current Ratio

277.44

ROA

2.1%

Financial History

Insufficient data

ShareholdersEnterprise Register · 19/11/2025

JUR.AS "RECIPE PLUS"

43.18%35,000,000

JUR.Sabiedrība ar ierobežotu atbildību "CENTRĀLĀ LABORATORIJA"

37.01%30,000,000

JUR.AS "RPH MARKETING LATVIA"

18.51%15,000,000

JUR.AS "NIPO"

1.23%1,000,000

JUR.AS "Repharm"

0.06%50,000

Beneficial Owners

Officials

Executive Board

Korņijenko Sergejs

Board Member

Tavjevs Roberts

Chair of Board

Power of AttorneyEnterprise Register · 19/11/2025

No prokūra data

Timeline

19/11/2025

UBO declared: Sergejs Korņijenko

Sergejs Korņijenko

19/11/2025

UBO declared: Andrejs Leibovičs

Andrejs Leibovičs

19/11/2025

UBO declared: Roberts Tavjevs

Roberts Tavjevs

21/11/2023

Capital: Apmaksātais pamatkapitāls 81050000 EUR

81050000 EUR

15/11/2023

SIA shareholder: AS "Repharm" (50000 shares)

AS "Repharm" (50000 shares)

15/11/2023

SIA shareholder: AS "RECIPE PLUS" (35000000 shares)

AS "RECIPE PLUS" (35000000 shares)

15/11/2023

SIA shareholder: Sabiedrība ar ierobežotu atbildību "CENTRĀLĀ LABORATORIJA" (30000000 shares)

Sabiedrība ar ierobežotu atbildību "CENTRĀLĀ LABORATORIJA" (30000000 shares)

15/11/2023

SIA shareholder: AS "RPH MARKETING LATVIA" (15000000 shares)

AS "RPH MARKETING LATVIA" (15000000 shares)

SIA "RPH INVEST" — Izlūks